CD44 and neoplasm: Layer-by-layer surface modification with hyaluronic acid (HA) and DOX resulted in a multifunctional nanoplatform that could actively target CD44+ overexpressed tumour cells, a characteristic feature of various cancers, associated with tumour progression, metastasis, and resistance to chemotherapy [85].